Log in
NASDAQ:ATEC

Alphatec Stock Forecast, Price & News

$10.60
-0.35 (-3.20 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$9.30
Now: $10.60
$11.28
50-Day Range
$8.46
MA: $9.81
$10.95
52-Week Range
$2.19
Now: $10.60
$11.51
Volume1.65 million shs
Average Volume674,220 shs
Market Capitalization$831.31 million
P/E RatioN/A
Dividend YieldN/A
Beta1.39
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to meet the surgeon's needs and to maximize patient outcomes; LLICO access system, a minimally invasive posterior thoracolumbar access system; Invictus Spinal Fixation System, a comprehensive thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep designed to improve surgical efficiency without compromising accuracy. It also provides Arsenal spinal fixation system intended for posterior, non-cervical fixation in skeletally mature patients for treating degenerative disc disease, spondylolisthesis, fracture or dislocation, spinal stenosis, curvatures, tumor, pseud arthrosis, and failed previous fusion; zodiac degenerative spinal fixation system, a comprehensive spinal system used to address degenerative spinal conditions and deformity correction; OsseoScrew system to restore the integrity of the spinal column; trestle luxe anterior cervical plate system; and solanas posterior cervico/thoracic fixation system and avalon occipital plate. In addition, the company offers IdentiTi Porous Ti and Transcend Lateral Interbody Implants; Battalion PC; Novel SD; Solus Anterior Lumbar Interbody Fusion System. Further, it is developing EOS imaging products. Additionally, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Read More
Alphatec logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.23 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ATEC
CUSIP02081G10
Phone760-431-9286
Employees227

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$113.43 million
Book Value$0.10 per share

Profitability

Net Income$-57,000,000.00

Miscellaneous

Market Cap$831.31 million
Next Earnings Date3/4/2021 (Estimated)
OptionableNot Optionable
$10.60
-0.35 (-3.20 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Alphatec (NASDAQ:ATEC) Frequently Asked Questions

How has Alphatec's stock been impacted by COVID-19 (Coronavirus)?

Alphatec's stock was trading at $4.41 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ATEC shares have increased by 140.4% and is now trading at $10.60.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Alphatec?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Alphatec
.

What stocks does MarketBeat like better than Alphatec?

Wall Street analysts have given Alphatec a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Alphatec wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Alphatec's next earnings date?

Alphatec is scheduled to release its next quarterly earnings announcement on Thursday, March 4th 2021.
View our earnings forecast for Alphatec
.

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) issued its earnings results on Thursday, November, 5th. The medical technology company reported ($0.24) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.25) by $0.01. The medical technology company had revenue of $41.16 million for the quarter, compared to analyst estimates of $40.83 million. Alphatec had a negative net margin of 51.95% and a negative return on equity of 266.45%.
View Alphatec's earnings history
.

What guidance has Alphatec issued on next quarter's earnings?

Alphatec updated its FY 2020 After-Hours earnings guidance on Thursday, November, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $143.5-146 million, compared to the consensus revenue estimate of $140.14 million.

What price target have analysts set for ATEC?

6 brokers have issued 1 year target prices for Alphatec's stock. Their forecasts range from $9.00 to $15.00. On average, they expect Alphatec's stock price to reach $12.17 in the next twelve months. This suggests a possible upside of 14.8% from the stock's current price.
View analysts' price targets for Alphatec
.

Are investors shorting Alphatec?

Alphatec saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 3,320,000 shares, an increase of 13.7% from the September 30th total of 2,920,000 shares. Based on an average daily trading volume, of 902,000 shares, the days-to-cover ratio is presently 3.7 days. Approximately 7.5% of the company's stock are sold short.
View Alphatec's Short Interest
.

Who are some of Alphatec's key competitors?

What other stocks do shareholders of Alphatec own?

Who are Alphatec's key executives?

Alphatec's management team includes the following people:
  • Mr. Patrick S. Miles, Exec. Chairman, CEO & Pres (Age 54, Pay $1.23M)
  • Mr. Jeffrey G. Black, Exec. VP & CFO (Age 51, Pay $652.76k)
  • Mr. David P. Sponsel, Exec. VP of Sales (Age 41, Pay $768.18k)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel (Age 56)
  • Mr. Brian R. Snider, Exec. VP of Marketing & Devel. (Age 42)
  • Mr. Jonathan Allen, Exec. VP of Commercial Operations (Age 60)
  • Dr. Luiz Pimenta, Chief Medical Officer
  • Ms. Kelli Mari Howell, Exec. VP of Clinical Strategies (Age 46)
  • Mr. Mark D. Ojeda, Exec. VP of Cervical & Biologics (Age 50)
  • Mr. Eric Dasso, Exec. VP of Adjunctive Technologies (Age 47)

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.71%), Penn Capital Management Co. Inc. (2.65%), Archon Capital Management LLC (1.71%), New York State Common Retirement Fund (1.44%), Royce & Associates LP (1.22%) and Parian Global Management LP (0.99%). Company insiders that own Alphatec stock include Craig E Hunsaker, David Sponsel, Evan Bakst, James L L Tullis, Jeffrey G Black, Jeffrey P Rydin and Kelli Mari Howell.
View institutional ownership trends for Alphatec
.

Which major investors are selling Alphatec stock?

ATEC stock was sold by a variety of institutional investors in the last quarter, including Penn Capital Management Co. Inc., JPMorgan Chase & Co., BlackRock Inc., New York State Common Retirement Fund, Archon Capital Management LLC, Squarepoint Ops LLC, AQR Capital Management LLC, and Quilter Plc. Company insiders that have sold Alphatec company stock in the last year include Craig E Hunsaker, David Sponsel, James L L Tullis, Jeffrey G Black, and Jeffrey P Rydin.
View insider buying and selling activity for Alphatec
.

Which major investors are buying Alphatec stock?

ATEC stock was acquired by a variety of institutional investors in the last quarter, including Parian Global Management LP, Morgan Stanley, Perkins Capital Management Inc., Oberweis Asset Management Inc., State Street Corp, CX Institutional, Blair William & Co. IL, and Cubist Systematic Strategies LLC. Company insiders that have bought Alphatec stock in the last two years include David Sponsel, Evan Bakst, and Kelli Mari Howell.
View insider buying and selling activity for Alphatec
.

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $10.60.

How big of a company is Alphatec?

Alphatec has a market capitalization of $831.31 million and generates $113.43 million in revenue each year. The medical technology company earns $-57,000,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. Alphatec employs 227 workers across the globe.

What is Alphatec's official website?

The official website for Alphatec is www.atecspine.com.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.